L’Oréal (ENXTPA:OR) has completed a €4b acquisition of Kering Beauté. The deal includes exclusive beauty rights for Creed, Balenciaga, and Bottega Veneta. The company and Kering have formalized a long-term partnership focused on luxury, wellness, and longevity.
L’Oréal, a global beauty group with a wide portfolio spanning mass, premium, and luxury brands, is adding more depth to its high end offering with Kering Beauté. For readers tracking the luxury segment, this deal sits at the intersection of prestige fragrance, fashion house licenses, and wellness adjacent products, all areas that have drawn strong consumer interest in recent years. The transaction gives L’Oréal a larger role in luxury fragrance and beauty tied to fashion labels that many consumers already know.
For investors watching ENXTPA:OR, the acquisition and new partnership broaden the range of product and licensing options the company can pursue with Kering. The formal framework for collaboration in luxury, wellness, and longevity sets up a wider playing field for future product launches, brand extensions, and new categories that could matter for L’Oréal’s mix over time.
Stay updated on the most important news stories for L’Oréal by adding it to your watchlist or portfolio. Alternatively, explore our Community to discover new perspectives on L’Oréal.
ENXTPA:OR Earnings & Revenue Growth as at Apr 2026
📰 Beyond the headline: 0 risks and 2 things going right for L’Oréal that every investor should see.
This €4b deal gives L’Oréal a larger seat at the high end of beauty, with Creed adding an established luxury fragrance house and 50 year licenses for Bottega Veneta and Balenciaga locking in long term access to fashion led brands. For a business that already competes with groups like Estée Lauder and Coty, control of more luxury licenses can help fill gaps in its portfolio and deepen relationships with consumers who trade up to premium products. The future transfer of Gucci beauty rights after 2028 adds another potential lever, although it sits on a longer timetable.
How This Fits Into The L’Oréal Narrative The acquisition supports the existing focus on premium products and brand strength, which sits alongside the narrative around growth from emerging markets and e commerce. The added luxury exposure increases execution demands in a segment where consumer preferences can shift quickly, which ties back to narrative references to competition from local and digital native brands. The move into wellness and longevity through a joint venture with Kering is only briefly touched on in the narrative and may represent an additional potential driver that is not fully covered.
Knowing what a company is worth starts with understanding its story.
Check out one of the top narratives in the Simply Wall St Community for L’Oréal to help decide what it’s worth to you.
The Risks and Rewards Investors Should Consider ⚠️ Execution risk on integrating Kering Beauté and managing multiple 50 year licenses across Creed, Balenciaga and Bottega Veneta. ⚠️ Higher exposure to luxury fragrances and beauty can increase sensitivity to competition from players like Estée Lauder and Coty, as well as to changes in premium consumer demand. 🎁 Expanded luxury portfolio through Creed and long dated licenses may support product mix and pricing power within L’Oréal Luxe. 🎁 The formal partnership with Kering in wellness and longevity opens access to new categories that could diversify revenue sources over time. What To Watch Going Forward
From here, it is worth watching how quickly L’Oréal refreshes and expands the Creed, Balenciaga and Bottega Veneta lines, and how the transition plan for Gucci beauty develops as current contracts run their course. The shape of any joint venture projects in wellness and longevity will also help show whether this partnership remains focused on fragrances or grows into a wider beauty and health platform. For investors, updates on integration costs, licensing terms and early product launches linked to Kering Beauté will be key signals.
To ensure you’re always in the loop on how the latest news impacts the investment narrative for L’Oréal, head to the
community page for L’Oréal to never miss an update on the top community narratives.
This article by Simply Wall St is general in nature. We provide commentary based on historical data
and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your
financial situation. We aim to bring you long-term focused analysis driven by fundamental data.
Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.
Simply Wall St has no position in any stocks mentioned.
New: AI Stock Screener & Alerts
Our new AI Stock Screener scans the market every day to uncover opportunities.
• Dividend Powerhouses (3%+ Yield)
• Undervalued Small Caps with Insider Buying
• High growth Tech and AI Companies
Or build your own from over 50 metrics.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
